1920.5000 -10.80 (-0.56%)
NSE Nov 20, 2025 15:31 PM
Volume: 23,799
 

1920.50
-0.56%
ICICI Securities Limited
Q4FY21 revenues grew 29.5% YoY to | 279 crore. EBITDA margins improved 575 bps YoY to 30.7% due to lower gross margins in the base year due to certain one-offs. Subsequently, EBITDA grew 59.3% YoY to | 86 crore. PAT grew 35.8% YoY to | 66 crore due to lower other income. On a...
ICICI Direct decreased Buy price target of Caplin Point Laboratories Ltd. to 2295.0 on 10 Nov, 2025.
More from Caplin Point Laboratories Ltd.
Recommended